A landmark study published in The Lancet Public Health reveals that cardiovascular disease (CVD) has firmly established itself as the primary driver of mortality and morbidity across the Association of Southeast Asian Nations (ASEAN). Drawing on data from the Global Burden of Disease Study 2021, researchers found that the number of individuals living with CVD in the region skyrocketed by 148.1% between 1990 and 2021.

By 2021, the regional burden had reached a critical mass, with 36.8 million prevalent cases and 1.66 million deaths. Collectively, the region lost 42.4 million disability-adjusted life-years (DALYs) to heart-related conditions.

Regional Disparities: Highest Rates in Laos and Malaysia

The study highlights significant heterogeneity among the ten member states. While the overall numbers are rising, specific countries face unique challenges:

• Highest Prevalence: Malaysia recorded the highest age-standardized prevalence rate, followed closely by Indonesia.
• Highest Mortality: Laos reported the most severe age-standardized mortality rate, with 410.9 deaths per 100,000 people.

The “Big Five” Drivers of Heart Disease

The research identified five modifiable risk factors that account for the vast majority of the CVD burden in ASEAN:

[Image of cardiovascular disease risk factors]

1. High Systolic Blood Pressure: The single most impactful metabolic risk factor.
2. Dietary Risks: Including high sodium intake and low consumption of whole grains.
3. Air Pollution: A growing environmental hazard across Southeast Asian urban centers.
4. High LDL Cholesterol: Driven by changing dietary patterns.
5. Tobacco Use: Continues to be a major contributor to vascular damage.

Urgent Need for Tailored Health Interventions

Lead author Marie Ng emphasizes that an aging population and rapid socioeconomic changes will likely push these numbers even higher. “Without immediate, country-specific action,” the study warns, “these preventable conditions will continue to cause escalating death and disability across the region.”